Interfraction physical dose variations in high-dose-rate brachytherapy for carcinoma cervix based on computed tomography image dataset to find the compatibility of the first fraction plan to treat successive fractions ABSTRACT Context: Due to limited resources and/or affordability by majority of the patients, many centers in low-and middle-income countries are still not able to adapt three-dimensional image-based brachytherapy planning in their routine practice.
INTRODUCTION
Intracavitary brachytherapy (ICBT) is an effective modality of treatment either alone or in combination with external beam radiotherapy for the treatment of gynecological malignancies. Initially, ICBT in carcinoma cervix had been based on the low-dose-rate brachytherapy system worldwide. [1] With the introduction of remote afterloading units and artificial radionuclide, for example, 192 Ir, high-dose-rate (HDR) brachytherapy became popular for ICBT due to its logistical benefits. The radiobiological disadvantage of HDR brachytherapy can be altered by delivering small doses in multiple HDR brachytherapy fractions and the use of three-dimensional (3D) image-based planning for improved and more accurate dosimetry for the target as well as organs at risk (OARs). [2, 3] The major benefit claimed for HDR brachytherapy insertions is the chance to gain a better physical dose distribution by careful positioning and better packing due to short duration of treatment. [4, 5] The practices of brachytherapy have been depending mainly on orthogonal radiographs. As in orthogonal radiograph based planning prescription, recording and reporting is limited to certain points only, it do not provide dose-volume relationship for tumor and various organs at risk. [6] The use of 3D imaging modality had been quite slow in brachytherapy practices as compared to external beam radiation therapy where multimodality imaging had been in wide use since the inception of advanced treatment techniques, for example, 3D conformal radiotherapy and intensity-modulated radiotherapy. Initially, 3D imaging mainly computed tomography (CT) was used for multiplanar reconstruction (MPR) to overcome the limitations of orthogonal radiograph-based planning. MPR images used for reconstruction of applicators and locating various dosimetric points of interest as required by orthogonal radiograph-based planning but anatomical dosimetric information were almost ignored. Application of 3D imaging, especially CT and magnetic resonance imaging (MRI) offering better definition of various types of tissues, is increasing worldwide. Publications of 3D image-based brachytherapy planning guidelines by the American Brachytherapy Society (ABS) [7] and The Groupe Européen de Curiethérapie (GEC) and the European Society for Radiotherapy & Oncology (ESTRO) (GEC-ESTRO) [8, 9] created enthusiasm in a number of well-equipped radiation oncology departments to use MRI for ICBT planning. This opened a new era of brachytherapy planning which had been broadly based on orthogonal radiographs since the initial years of the twentieth century. Unavailability of MRI compatible applicators and MRI facility in most of the radiation oncology clinics has been a major hurdle in adapting this modality in routine practice. Multidetector CT has become 3D imaging modality of choice for image-guided brachytherapy (IGBT) planning due to its availability in most of the radiation oncology clinics having the capabilities of submillimeter resolution and better tissue definitions. The same has been endorsed by a recent survey conducted by the Gynecologic Cancer Intergroup which revealed that CT scan is the most common imaging modality used worldwide. [10] The International Commission on Radiation Units and Measurements in its report for prescribing, recording, and reporting brachytherapy for cancer of the cervix (ICRU-89) strongly recommended individualized 3D image-based brachytherapy treatment planning for each fraction. [11] The changes in doses of tumor and OARs (rectum and bladder) between two insertions can have important clinical significance, so it is essential to find the OAR doses and tumor doses during each and every insertion. Besides availability of advance imagining technology, many centers in low-and middle-income countries due to heavy patient load are still forced to practice orthogonal radiograph-based planning due to constraints of limited resources (deficit of workforce, time, facilities, etc.). [12] Therefore, IGBT planning for each fraction is not feasible at many centers having limited resources. To overcome this constraint, a viable option may be to use dosimetric parameters of the first fraction treatment plan based on 3D CT/MRI imaging dataset during treatment of subsequent fractions. However, to validate the feasibility of such option, dosimetric differences due to adaptation of the first fraction parameters for successive fractions with original plan of successive fractions need to be investigated. If these differences are within acceptable dosimetric variations, then it may be safe to use dosimetric parameters of the first fraction to treat successive fractions. The current work represents a feasibility study for finding the compatibility of 3D CT image dataset-based first fraction plan for treating successive fractions in cervix HDR brachytherapy by means of flexible applicator.
MATERIALS AND METHODS
Retrospectively, 114 3D CT image dataset-based plans of 38 patients (38 × 3 insertions = 114 plan) who have received intracavitary treatment for carcinoma cervix with HDR brachytherapy machine have been chosen for the study. The distribution (mean ± standard deviation [SD]) of patients' age was 50 ± 8.80 years, and the disease stage ranges from IB to IVA of the International Federation of Gynecology and Obstetrics (FIGO) staging system. All the patients have received a dose of 46-50 Gy (2 Gy per fraction for 23-25 fractions over a period of 5 weeks) by external beam radiotherapy either on telecobalt unit or on 6 MV medical linear accelerator using either two parallel opposed AP-PA portals or four-field box technique before brachytherapy treatments. After completion of external beam radiotherapy, all patients have been planned to receive a dose of 21 Gy (7 Gy/fraction × 3 fractions on weekly interval) by means of ICBT using flexible geometry Fletcher-style tandem and ovoid (TO) applicator. Before applicator insertion, patients have been explained about the whole procedure of image-based brachytherapy treatment, and informed consent has been obtained. The applicator insertions have been performed under general anesthesia with all aseptic precautions. Adequate vaginal packing has been done using povidone-iodine (Betadine) soaked gauge for immobilization and to avoid slippage of applicator assembly. Foley's catheter inserted into urinary bladder and balloon has been inflated with 7 cc of radio-opaque solution. The urinary catheter has been left to drain in all the patients. Postinsertion, 3D images have been acquired on CT simulator (Discovery RT, GE Healthcare) from umbilicus to mid-thigh with 5-mm slice thickness. Acquired images have been imported into 3D computerized brachytherapy planning system (BrachyVision version 13.6.32; Varian Medical Systems International AG, Switzerland) through local area network. Applicator reconstruction and contouring of critical organs (bladder and rectum) was performed by a radiation oncologist following the ABS/GEC-ESTRO [7] [8] [9] guidelines. To avoid interpersonal variations, all applicator insertions and contouring were performed by a single radiation oncologist.
The brachytherapy treatment plans based on CT image datasets of each fraction, i.e., Plan 1, Plan 2, and Plan 3, have been created as per the ABS guidelines, and the dose of 7 Gy has been prescribed to mean of point "A." The treatment plans have been optimized in such a way that total EQD 2 doses including external beam radiotherapy and brachytherapy remained below 75 Gy for the rectum and 90 Gy for the bladder. Brachytherapy treatments have been delivered to patients with 192 Ir HDR brachytherapy source using a remote afterloading machine (GammaMedplus, Varian Medical Systems). As per established guidelines, [7] [8] [9] 11] dose-volume parameters used for reporting OAR doses are minimum doses received by maximum volume of 2.0 cc (D Bla2cc / D Rec2cc ), 1.0 cc (D Bla1cc /D Rec1cc ), and 0.1 cc (D Bla0.1cc /D Rec0.1cc ) have been estimated from cumulative dose-volume histogram for the bladder and rectum, respectively [ Figure 1 ].
For estimation of interfraction variations, the difference in mean point "A" dose between Plan 1 and Plan 2 (D A1-2 ), between 
, respectively, has been calculated. To assess the dosimetric differences due to adaptation of the first fraction plan for the successive fraction treatments, revised plan on CT image dataset of the second and third fractions Plan 2R and Plan 3R has been generated by copying the dwell position and dwell times of corresponding the first fraction treatment on the reconstructed applicator set of the second and third fractions, respectively. The difference between original and revised plans Plan 2 and Plan 2R and Plan 3 and Plan 3R has been D A2-2R , D A3-3R ,
, and D Rec0.1cc3-3R evaluated, respectively, for mean point "A" dose, bladder, and rectum.
Statistical analysis
Statistical software package SPSS version 20 (IBM corporation, New York, USA was used for statistical analysis. Descriptive analysis was performed to determine the mean ± SD doses of OAR and target. A paired two-tailed t-test was performed to assess the statistical significance of differences between the plans. P < 0.05 was considered for significance of statistical inferences.
RESULTS
The values of mean dose to point "A" and dose-volume parameters for OARs have been presented in Table 1 for original and revised plans, respectively. The mean point "A" doses have been found 6.91 ± 0.13 Gy, 6.93 ± 0.15 Gy, and 6.87 ± 0.29 Gy for consecutive original plans and 6.75 ± 0.44 Gy and 6.88 ± 0.41 Gy for revised plans, respectively. The statistical differences of mean point A doses D A1-2 , D A1-3 , D A2-3 , and D A3-3R have been found insignificant except D A2-2R (P = 0.01 < 0.05) [ Table 2 ].
The mean values of D Bla2cc have been found 6.17 ± 0.81 Gy, 6.16 ± 1.08 Gy, and 6.16 ± 0.80 Gy for consecutive original plans and 6.14 ± 1.26 Gy and 6.36 ± 1.22 Gy for revised plans.
The mean values of D Bla1cc have been found 6.75 ± 0.94 Gy, 6.73 ± 1.24 Gy, and 6.69 ± 0.91 Gy for consecutive original plans and 6.78 ± 1.38 Gy and 6.85 ± 1.37 Gy for revised plans.
The mean values of D Bla0.1cc have been found 8.27 ± 1.40 Gy, 8.34 ± 1.53 Gy, and 8.00 ± 1.35 Gy for consecutive original plans and 8.16 ± 1.81 Gy and 8.20 ± 1.86 Gy for revised plans. The mean differences of none of the bladder dose-volume parameters have been found significant [ Table 3 ].
The mean values of D Rec2cc have been found 4.34 ± 0.74 Gy, 4.50 ± 0.97 Gy, and 4.61 ± 0.80 Gy for consecutive original plans and 4.49 ± 1.09 Gy and 4.87 ± 1.17 Gy for revised plans. The mean values of D Rec1cc have been found 4.74 ± 0.87 Gy, 4.94 ± 1.10 Gy, and 5.03 ± 0.94 Gy Table 3 ].
The results of the present dosimetric analysis revealed that there are statistically no significant differences between original plans of the first, second, and third insertions based on 3D CT image dataset of each fraction for the estimation of mean point "A" dose, bladder, and rectum dose-volume parameters (D 2.0 cc , D 1.0 cc , and D 0.10 cc ).
Furthermore, when the treatment planning parameter (dwell position and dwell time) of the first fraction plans has been imposed on CT image dataset of subsequent second and third fractions, the mean difference of point "A" dose has been found insignificant except D A2-2R , i.e., the mean difference of original and revised plan of the second fractions (P = 0.02 < 0.05). The mean differences of bladder and rectal dose-volume parameters have also found insignificant except D Rec0.1cc3-3R (P = 0.04 < 0.05). The present dosimetric analysis revealed no significant dose difference in the target dose neither between consecutive original plans nor between revised plans except between Plan 2 and Plan 2R where it showed a mean underdosing of about 18 cGy (2.5%) during the second fraction revised plan as compared to the second fraction original plan, and this difference was statistically significant (P = 0.02 < 0.05).
Similarly, the mean difference of doses to the bladder and rectum as estimated by D 2cc , D 1cc , and D 0.1cc found insignificant except D Rec0.1cc3-3R with a mean increase of about 36 cGy (5%) for revised plan as compared to original plan (P = 0.04 < 0.05).
DISCUSSION
3D CT image-based treatment planning for each fraction of ICBT reflects actual volumetric doses of OARs in comparison to using the first fraction 3D image-based treatment plan to treat subsequent fractions. The use of the first fraction plan for treating successive fractions caused mean underdosing of 2.5% for the tumor (for the second fraction original vs. revised) and mean overdosing of 5% for rectum (for the third fraction original vs. revised). These dosimetric differences are well within the acceptable dosimetric variation of ±5%. A retrospective study by Co JL et al. analyzed the plans of 29 patients treated using 2D orthogonal radiograph-based plans. They compared the dosimetric differences between customized plan of each fraction and using plan of the first fraction for the treatment during subsequent second and third fractions. They could not find any statistically significant difference but strongly recommended to do replanning for each fraction wherever feasible. [13] Davidson et al. reported that a duplication of planned dwell times and positions from one insertion to the next does not duplicate dose distributions in HDR cervix applications. A single plan used for an entire course of brachytherapy can result in significant increase to OAR doses for tandem and ring applicator and unpredictable OAR doses for TO applicators. Hence, treatment plans should be tailored for each insertion to reflect current applicator and anatomical geometry. [14] Mobit et al. in their study on 3D image-based customized versus standard treatment planning for cervical cancer HDR brachytherapy with TOs reported no significant differences between customized and standard plans for the bladder and rectum as indicated by D 2cc ; however, a significant number of standard plans failed to meet planning constraint set for image-based customized plan. [15] The advantage of individualized treatment planning for each HDR brachytherapy applications has been proven using repetitive CT by Hellebust et al., [16] MRI by Kirisits et al., [17] and radiographs by Jones et al. [18] These studies suggested that changes in applicator geometry and anatomy during multiple HDR applications can produce dosimetric changes if single plan is used in subsequent fractions. Hellebust individualized treatment planning in HDR TO insertions for the treatment of cervix cancer. Thus, the findings of the present study are similar to the findings reported in a number of publications in the recent past with a limitation of using mean point "A" for target dose prescription instead of prescribing to high-risk clinical target volume (HR-CTV). As recommended by various image-based brachytherapy groups, HR-CTV could not be delineated due to use of incompatible applicator which caused a lot of artifacts in the CT images.
CONCLUSIONS
The results of the present study and similar studies by other researchers have not shown any significant dosimetric differences due to the use of customized or standard plans. However, considering the clinical sensitiveness of small deviation in doses to the tumor or OAR, most of the studies recommended to use customized plans as far as institutional constraints allow doing so. The results of the present study show that neither the tumor dose nor doses to OAR are much different due to the use of the first fraction plan for treating successive fractions. In other words, we can say that the dosimetric differences caused for tumor and OARs due to the use of standard plan instead of doing customized planning for each fraction are within acceptable dosimetric accuracy required for clinical radiotherapy. Therefore, on the basis of the present study, it may be concluded that centers working with limited resources may use the first fraction treatment plan based on 3D CT image dataset for treatment of successive fractions with flexible geometry applicator by careful applicator insertions, proper packing, and treatment planning. In this study, mean point "A" dose has been used as surrogate for tumor dose instead of actual tumor volume, and dose-volume relationship is missing in its completeness for tumor volume. Our findings have demonstrated the need for further studies on volumetric image-based brachytherapy treatment planning providing better details of dose-volume relationship for tumor along with OARs. On the basis of previous studies based on advanced imaging and recent guidelines for dose prescription, recording, and reporting, it is suggested that image-based customized planning for each fraction should be preferred and the use of standard plan should be attempted only when limitation of workforce and other resources poses major hurdle for doing so.
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